Ligand validation:2Y69

PGV: (1R)-2-{[{[(2S)-2,3-DIHYDROXYPROPYL]OXY}(HYDROXY)PHOSPHORYL]OXY}-1-[(PALMITOYLOXY)METHYL]ETHYL (11E)-OCTADEC-11-ENOATE

PGV is a Ligand Of Interest in 2Y69 designated by the RCSB

	Best-fitted instance in this entry
	Other instances in this entry

	Best-fitted instance in this entry
	Best-fitted PDB instances with same target (top 5)

	Best-fitted instance in this entry
	Best-fitted PDB instances with different target (top 5)

Identifier	Ranking for goodness of fit	Ranking for geometry	Real space R factor	Real space correlation coefficient	RMSZ-bond-length	RMSZ-bond-angle	Outliers of bond length	Outliers of bond angle	Atomic clashes	Stereochemical errors	Model completeness	Average occupancy
2Y69_PGV_C_1263	80%	49%	0.115	0.965	0.9	1.08	2	3	2	0	100%	1
2Y69_PGV_C_1264	74%	52%	0.125	0.956	0.91	0.94	2	4	6	0	100%	1
2Y69_PGV_P_1263	74%	45%	0.12	0.949	0.9	1.21	2	5	5	0	100%	1
2Y69_PGV_P_1264	71%	52%	0.129	0.951	0.88	0.97	3	4	10	0	100%	1
5B1A_PGV_P_303	98%	35%	0.064	0.985	1.06	1.51	3	13	8	0	100%	1
5X1B_PGV_C_302	95%	52%	0.078	0.981	0.92	0.93	2	4	0	0	100%	1
5B1B_PGV_C_302	94%	56%	0.078	0.979	0.81	0.87	1	1	3	0	100%	1
7YPY_PGV_P_302	94%	54%	0.079	0.978	0.79	0.99	2	2	1	0	100%	1
5ZCQ_PGV_N_608	90%	32%	0.094	0.978	1.15	1.53	5	8	1	0	100%	1
7VUW_PGV_A_608	90%	48%	0.096	0.979	0.89	1.12	2	3	1	0	100%	1

RCSB PDB Core Operations are funded by the U.S. National Science Foundation (DBI-2321666), the US Department of Energy (DE-SC0019749), and the National Cancer Institute, National Institute of Allergy and Infectious Diseases, and National Institute of General Medical Sciences of the National Institutes of Health under grant R01GM157729.